Abby Kennedy, Ph.D.

Abby Kennedy joined Jasper in 2025 as Vice President, Clinical Operations. Dr. Kennedy has over 20 years of pharmaceutical industry experience primarily in clinical operations. Dr. Kennedy most recently served as Head of Clinical Operations at DermBiont, an early-phase dermatology-focused company. Prior to DermBiont, she was VP of Clinical Operations at CymaBay Therapeutics, leading a team that successfully brought seladelpar to market for patients with primary biliary cholangitis, and before that she was Sr. Director of Clinical Operations at Principia Biopharma, where she led the late phase program for Principia’s lead molecule, rilzabrutinib. Earlier in her career she held positions in clinical operations at Genentech, XOMA and Exelixis. Dr. Kennedy received a BS in chemistry from Allegheny College and a Ph.D. in organic chemistry from the University of Arizona. Over the past 20 years, she has served as a volunteer and mentor for ACS, AWIS, HBA, the Association for Clinical Research Professionals (ACRP), Oakland Girls’ Softball League and the Oakland High Parent Teacher Organization.